Insider Shareholders with Direct Ownership of Acorda Therapeutics Inc (ACOR)
This section provides a comprehensive overview of the insiders with direct ownership of Acorda Therapeutics Inc (ACOR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ACORDA THERAPEUTICS INC Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Ron Cohen
President and CEO |
49,156 | 6,229 | 149,757 $38,936 | 5 |
Mar 17, 2023
Added 6.26%
|
Burkhard Blank
CMO and Head of R&D |
11,125 | 0 | 18,527 $4,817 | 1 |
Mar 03, 2021
Added 37.52%
|
David Lawrence
Chief, Bus. Ops & PAO |
0 | 2,165 | 13,811 $3,590 | 2 |
Dec 01, 2020
Reduced 7.63%
|
Lauren M Sabella
Chief Operating Officer |
11,125 | 3,022 | 10,710 $2,784 | 3 |
Sep 03, 2022
Reduced 12.36%
|
Kerry M Clem
Chief Commercial Officer |
0 | 1,511 | 10,083 $2,621 | 1 |
Sep 03, 2022
Reduced 13.03%
|
Robert Morales
Interim PAO & PFO |
0 | 448 | 4,423 $1,149 | 1 |
Sep 03, 2021
Reduced 9.2%
|